Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Sebia
| Company | Sebia |
|---|---|
| Name of instrument | dIFine P30 Processor |
| Contact | Marketing |
| City, State | Branchburg, NJ |
| Phone | 908-526-3744 |
| Website | |
| Type of instrument | immunoassay |
| Operational type/Model type | batch/benchtop |
| List price/First year sold in U.S. | — |
| Targeted hospital bed size/Targeted test volume | annual: > 5, 000 |
| Company manufactures instrument | no |
| Other models in this family of analyzers | — |
| No. of units in clinical use in U.S./Outside U.S. (countries) | — |
| Dimensions (H × W × D)/Instrument footprint | 29.1 x 34.6 x 33.1 in./8 sq. ft. |
| Weight empty/Weight fully loaded | 220 lbs./— |
| No. of different measured assays onboard simultaneously | 30 (30 can be run and calibrated at one time) |
| No. of user-definable (open chemistry) channels | — |
| Test throughput per hour/Assay run time | assay dependent/— |
| No. of direct ion-selective electrode channels | — |
| Detection methods | — |
| • Ion-selective electrode | — |
| • Basic metabolic panel | — |
| • Complete metabolic panel | — |
| Typical time delay from ordering stat test until aspiration of sample | — |
| Fully automated microplate immunoassay system | no |
| Methodologies supported | fluorescence |
| Separation methodologies | IFA slide well washing |
| Stat time until completion of a ß-hCG test | — |
| Stat time until completion of a cTn test | — |
| • Typical time delay from test order to aspiration of sample | — |
| Approximate No. of tests per reagent set/Reagent type | 80–240/open reagent system |
| Reagents refrigerated onboard/Reagents ready to use | no/yes |
| Reagent lot tracking/Reagent inventory | yes/yes |
| Reagent form/Reagents barcoded | liquid chemistry (open reagent system)/yes |
| Separate reagent pack for each specimen/for each test run | no/yes |
| Walkaway capability/Walkaway duration | yes/240 specimens or 30 tests |
| Design of sample-handling system | rack |
| Uses washable cuvettes/Uses disposable cuvettes | no/no |
| Min.–max. sample volume that can be aspirated at one time | 10–1, 000 µL |
| Min. reaction volume/Min. specimen volume/Min. dead volume | — |
| Dedicated pediatric sample cup | yes |
| Primary tube sampling | yes |
| Accommodates most standard tube sizes/Accepts nonstandard tube sizes | yes/no |
| Pierces caps on primary tubes | no |
| Protects against probe collision | no |
| Detects clots/liquid level/short sample | no/yes/yes |
| Detection or quantitation for hemolysis, icterus, lipemia, clots | hemolysis, icterus, lipemia, clots not available |
| Dilutes patient samples onboard/Susceptibility to carryover | yes (can be programmed to perform dilutions prior to analysis)/— |
| Sample volume can be diluted to rerun out-of-linear-range high results | no |
| Sample volume can be concentrated to rerun out-of-linear-range low results | no |
| Analyzer requires dedicated water supply | no |
| Autocalibration/Multipoint calibration supported | no (calibrants are not stored onboard)/no |
| Typical calibration frequency for ISE/therapeutic drugs/drugs of abuse/general chemistries/immunoassays | — |
| Automatic programmable start/Automatic programmable shutdown | no/no |
| Supports multiple QC lot numbers per analyte | no |
| Waste management | automated collection onboard instrument |
| Sample barcode-reading capability/Autodiscrimination | yes (Interleaved 2 of 5, Codabar, Code 39, Code 128)/no |
| Lab can control analyzer from remote computer | yes |
| Instrument can diagnose its own malfunctions | yes (operator intervention required to order parts) |
| System malfunctions can be diagnosed via remote monitoring | yes |
| UPS backup power supply | no |
| Data-management capability/LIS or EHR systems interfaced | onboard/yes |
| LIS interface provided/Bidirectional interface capability | no/yes (host query) |
| Modem servicing provided/Service engineer on-site response time | no/within 24 hrs. |
| Mean time between failures | — (displays error codes for troubleshooting) |
| Average scheduled maintenance time by lab personnel | daily: performed automatically; weekly: 5 min.; monthly: 10 min. |
| Maintenance records kept onboard for user/vendor | no/no |
| Maintenance training demonstration module onboard | no |
| Training included with purchase/Avg. time for basic user training | yes (2 training slots)/3 days (at customer site) |
| Advanced operator training/Extra charge for follow-up or advanced training | yes (at customer site)/no |
| Warranty provided/Cost of annual service contract (24 h/7 d) | yes (1 year)/— |
| Distinguishing features (supplied by company) | processes up to 240 samples and 30 IFA slides with a small footprint; fully automated–performs dilution, incubation, washing, mounting, and coverslipping; reliable traceability of samples, reagents, and slides owing to integrated barcode readers |